IonQ Registers Potential Resale of 34,580,646 Shares Linked to Elisity Acquisition
Key Facts
On November 13, IonQ filed a prospectus supplement with the U.S. Securities and Exchange Commission allowing selling shareholders to resell up to 34,580,646 common shares. The shares are tied to the October 9 Elisity acquisition agreement and include shares issued or that may be issued to the acquired company's shareholders. IonQ said in the supplement that it will receive no proceeds from the sales, as the proceeds will go to the selling shareholders. The registration gives those shareholders the option to resell, but does not specify when or how many shares will actually be sold. The company said it does not know whether or when they will sell the shares, or in what amounts.
The registered cap covers holdings of several investors in Elisity, including up to 6,434,866 shares for Two Bear Capital and up to 6,172,764 shares for Cyber Innovation Partners. It also includes up to 5,890,852 shares for Insight Partners. The figures include vested shares and contingent earnout shares, according to the supplement. Therefore, the registered maximum does not mean these amounts will enter the market all at once or that all of them will be sold. The supplement allows shareholders to sell all, some or none of the shares.
IonQ completed the Elisity acquisition on November 3 for 32,233,274 shares, with sellers eligible for an additional earnout of up to 4,265,934 shares. The earnout is tied to Elisity achieving financial metrics during two periods ending on July 31, 2027, and January 31, 2028, and the number of shares earned could be below the maximum or zero. IonQ said sellers may receive additional consideration of up to $150 million based on achieving revenue targets through January 2028. The company described the acquisition as adding post-quantum cryptography and quantum key distribution to zero-trust security. It added that Elisity has more than 100 active enterprise deployments.
IonQ said in its filing that a large number of shares being sold, or the market's perception that sales may occur, could put pressure on the share price. But it said it cannot predict the effect or timing of sales, and the number of shares that will actually be sold is unknown. The warning reflects a possibility associated with the potential for resale, not confirmation that shareholders have begun selling. The registration also does not represent new financing for the company, because the resale proceeds will not go to IonQ. The registered shares are tied to the acquisition consideration paid or payable to Elisity shareholders.
The filing followed a decline in IonQ shares in previous sessions, with EL7 data showing a close of $35.34 on November 9, then $34.99 on November 10 and $34.06 on November 11. The stock closed at $30.86 on November 12, before ending the November 13 session at $28.88. In a report published by Benzinga on November 13, the stock was down 8.17% at $28.35 at the time of publication. The report also linked the move to a reshuffle of financial leadership and the departure of Inder M. Singh. The prospectus supplement, meanwhile, records that the last sale price on the New York Stock Exchange on November 12 was $30.86 per share.
The share registration follows IonQ's acquisition of cybersecurity company Elisity, as the company expands into security applications related to quantum computing. In its third-quarter results, IonQ said revenue rose 336% to $173.8 million in the period ended September 30, 2026, from $39.9 million a year earlier. The company attributed the growth to contracts to build specialized quantum computers and revenue from acquisitions. Revenue for the first nine months of the year was $318.5 million, up 368% from $68.1 million in the corresponding period. The company raised its 2026 revenue forecast to $505–515 million from $450–460 million, compared with analysts' estimate of $455.17 million.
IonQ disclosed that it had $1,662.4 million in cash and cash equivalents, and short- and long-term investments, on September 30, 2026. It also completed an offering in October that generated total proceeds of $1,990.0 million. In contrast, the company recorded an operating loss of $1,041.8 million during the nine months ended September 30, and said it expects to continue incurring substantial losses for the foreseeable future. The shareholders' pre-offering ownership percentages in the supplement were based on 462,881,896 shares outstanding on November 10. The vesting of earnout shares remains tied to Elisity achieving its targets through January 2028.